FDA approvaloutcome: successconf 1.00
baclofen — FDA approval
$ANIP · ANI PHARMACEUTICALS INC
Event date
June 8, 2023
1094 days ago
Sponsor runway
cash-flow +
$311.2M liquid
Evidence
Comparable historical fda approvals· last 5 years · same event type
100% hit rate (10/10)
| Ticker | Drug | Date | Outcome |
|---|---|---|---|
| $INCY | zynyz | 2026-05-18 | success |
| $INCY | jakafi xr | 2026-05-01 | success |
| $AXSM | auvelity | 2026-04-30 | success |
| $INCY | zynyz | 2026-03-30 | success |
| $BIIB | spinraza | 2026-03-27 | success |
| $CORT | lifyorli | 2026-03-25 | success |
| $RYTM | imcivree | 2026-03-19 | success |
| $ASND | yuviwel | 2026-02-27 | success |
| $BMRN | palynziq | 2026-02-27 | success |
| $ETON | desmoda | 2026-02-25 | success |
Recent insider activity· ±90 days
15 insiders · 0 buys · 25 sells
Sell10b5-1
2023-09-01Gassert Chad
SVP - CORP. DEV. & STRATEGY
20,000 @ $64.70$1.29M
Sell
2023-08-29Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
25,000 @ $63.37$1.58M
Sell
2023-08-28Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
25,000 @ $63.06$1.58M
Exercise
2023-08-23Marken James G.
SVP OPS & PROD DEV
1,667 @ $33.00$55K
Sell
2023-08-23Marken James G.
SVP OPS & PROD DEV
3,932 @ $63.00$248K
Exercise
2023-08-23Gutwerg Ori
SVP, GENERICS
13,502 @ $31.49$425K
Sell
2023-08-23Gutwerg Ori
SVP, GENERICS
2,059 @ $62.39$128K
Exercise
2023-08-23Marken James G.
SVP OPS & PROD DEV
3,750 @ $40.59$152K
Sell
2023-08-23Gutwerg Ori
SVP, GENERICS
13,502 @ $62.39$842K
Grant
2023-08-21Leonard Matthew J
Director
7,583 @ ——
Sell
2023-08-16MERIDIAN VENTURE PARTNERS II LP
10%+ Owner
200,000 @ $58.50$11.70M
Sell10b5-1
2023-08-15Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
22,110 @ $61.60$1.36M
Sell
2023-08-15Lalwani Nikhil
PRESIDENT & CEO
11,616 @ $61.13$710K
Exercise
2023-08-15Lalwani Nikhil
PRESIDENT & CEO
11,616 @ $29.00$337K
Sell
2023-08-14CAREY STEPHEN P.
SVP & CFO
17,639 @ $61.37$1.08M
Sell10b5-1
2023-08-14Pera Antonio R
Director
3,000 @ $60.37$181K
Sell10b5-1
2023-08-14Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
27,890 @ $61.15$1.71M
Sell
2023-08-11Lalwani Nikhil
PRESIDENT & CEO
56,666 @ $57.75$3.27M
Sell10b5-1
2023-08-01Gassert Chad
SVP - CORP. DEV. & STRATEGY
20,000 @ $51.06$1.02M
Sell10b5-1
2023-07-21Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
11,500 @ $52.56$604K
Sell10b5-1
2023-07-20Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
6,000 @ $51.52$309K
Sell10b5-1
2023-07-19Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
5,969 @ $51.48$307K
Tax
2023-07-18Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
1,743 @ $51.89$90K
Sell10b5-1
2023-07-18Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
6,700 @ $51.84$347K
Sell10b5-1
2023-07-17Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
9,831 @ $51.06$502K
Sell10b5-1
2023-07-14Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
10,000 @ $50.43$504K
Sell10b5-1
2023-07-03Gassert Chad
SVP - CORP. DEV. & STRATEGY
20,000 @ $53.43$1.07M
Sell10b5-1
2023-06-22Gassert Chad
SVP - CORP. DEV. & STRATEGY
20,000 @ $51.32$1.03M
Sell10b5-1
2023-06-22Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
13,500 @ $51.38$694K
Sell10b5-1
2023-06-21Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
11,843 @ $51.95$615K
Sell10b5-1
2023-06-20Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
14,657 @ $51.93$761K
Grant
2023-05-23TANNENBAUM RENEE P
Director
6,865 @ ——
Grant
2023-05-23Thoma Jeanne
Director
6,865 @ ——
Grant
2023-05-23HAUGHEY THOMAS
Director
6,865 @ ——
Grant
2023-05-23NASH DAVID
Director
6,865 @ ——
Grant
2023-05-23Walsh Patrick D
Director
6,865 @ ——
Grant
2023-05-23Pera Antonio R
Director
6,865 @ ——
Tax
2023-04-10CAREY STEPHEN P.
SVP & CFO
4,534 @ $38.50$175K
Tax
2023-04-10Marken James G.
SVP OPS & PROD DEV
2,289 @ $38.50$88K
Tax
2023-03-28Marken James G.
SVP OPS & PROD DEV
524 @ $38.62$20K
Tax
2023-03-28CAREY STEPHEN P.
SVP & CFO
1,420 @ $38.62$55K
Tax
2023-03-23Marken James G.
SVP OPS & PROD DEV
2,452 @ $37.82$93K
Tax
2023-03-23CAREY STEPHEN P.
SVP & CFO
4,224 @ $37.82$160K
Tax
2023-03-23Lalwani Nikhil
PRESIDENT & CEO
17,455 @ $37.82$660K